Mereo BioPharma Group plc — Investor Relations & Filings
Mereo BioPharma Group plc is a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for rare diseases with limited or no treatment options. The company's strategy involves acquiring and advancing promising clinical-stage product candidates that have been de-prioritized by larger pharmaceutical or biotechnology companies. This capital-efficient model allows it to develop a specialized pipeline. Its two lead programs are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat for Alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD). Mereo BioPharma also engages in strategic partnerships and out-licenses other clinical assets to deliver impactful treatments to patients.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Holding(s) in Company | 2017-04-24 | English | |
| Grant of Options and Awards | 2017-04-05 | English | |
| Results of Placing | 2017-04-03 | English | |
| Results of Placing | 2017-03-31 | English | |
| Proposed Placing | 2017-03-29 | English | |
| Posting of Annual Report and Notice of AGM | 2017-03-15 | English |
Browse filings by year
11 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2017
9 filings
| |||||
| 10446588 | Holding(s) in Company | 2017-04-24 | English | ||
| 10444352 | Grant of Options and Awards | 2017-04-05 | English | ||
| 10443673 | Results of Placing | 2017-04-03 | English | ||
| 10443600 | Results of Placing | 2017-03-31 | English | ||
| 10442739 | Proposed Placing | 2017-03-29 | English | ||
| 10439927 | Posting of Annual Report and Notice of AGM | 2017-03-15 | English | ||
| 10438202 | Positive recommendation for BGS-649 Phase 2b trial | 2017-03-07 | English | ||
| 10436437 | Preliminary Results | 2017-02-27 | English | ||
| 10435903 | EMA Adaptive Pathways programme accepts BPS-804 | 2017-02-20 | English | ||
|
2016
6 filings
| |||||
| 10430607 | Business Update | 2016-12-12 | English | ||
| 10426231 | Appointment of Chief Financial Officer | 2016-11-07 | English | ||
| 10426026 | Positive Phase 1 interaction study with BCT-197 | 2016-11-03 | English | ||
| 10422491 | Directorate Change | 2016-10-05 | English | ||
| 10420175 | Half-year Report | 2016-09-16 | English | ||
| 10416066 | Notice of Results | 2016-08-09 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for Mereo BioPharma Group plc, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Mereo BioPharma Group plc via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33281/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33281 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33281 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33281 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33281}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Mereo BioPharma Group plc (id: 33281)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.